Brincidofovir is a robust replication inhibitor against African swine fever virus <i>in vivo</i> and <i>in vitro</i>.

Noticeably, highly significant inhibition of ASFV replication was demonstrated when the brincidofovir was added 1 h after initial viral incubation at either 4 or 37°C (post-1 and post-2) ( Figure 4 (C)).

also in 132,142 other papers